Advertisement | ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
TABLE OF CONTENTS | ||||||||||||||||||||||||||||||||||||||
July 2014 Volume 10 Number 7 | ||||||||||||||||||||||||||||||||||||||
In this issue Research Highlights News and Views Addendum Reviews Perspectives
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
Advertisement | ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
NEWS AND VIEWS | Top | |||||||||||||||||||||||||||||||||||||
Chronic kidney disease: Should sodium intake be restricted in patients with CKD? Michel Burnier & Gregoire Wuerzner Published online: 20 May 2014 p363 | doi:10.1038/nrneph.2014.88 A reduction of salt intake to <5 g sodium chloride per day is generally advised for patients with chronic kidney disease. However, hard evidence to support this recommendation is lacking. New data from Fan et al. suggest that very strict sodium limits might be harmful in patients with renal disease. Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
End-stage renal disease: Dual transplantation—the immunological role of the liver Marc Martinez-Llordella & Alberto Sanchez-Fueyo Published online: 13 May 2014 p364 | doi:10.1038/nrneph.2014.78 Kidney transplant recipients who also receive a partial liver allograft have better long-term outcomes than those who receive a kidney alone, despite the more-complex surgery. Understanding how the liver exerts these beneficial effects might enable their exploitation in the future. Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
Transplantation: The relevance of the FAVORIT blood pressure associations Krista L. Lentine & Daniel C. Brennan Published online: 06 May 2014 p366 | doi:10.1038/nrneph.2014.79 Secondary analysis of the FAVORIT data in kidney transplant recipients showed that systolic blood pressure ≥140 mmHg and diastolic blood pressure <70 mmHg at trial entry were associated with increased risks of cardiovascular disease over a mean of 4 years. Whether these blood pressure values are associated with mortality is unclear. Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
ADDENDUM | Top | |||||||||||||||||||||||||||||||||||||
Addendum: The gut–renal axis: do incretin-based agents confer renoprotection in diabetes? Marcel H. A. Muskiet, Mark M. Smits, Linde M. Morsink & Michaela Diamant Published online: 02 May 2014 p362 | doi:10.1038/nrneph.2014.90 Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
REVIEWS | Top | |||||||||||||||||||||||||||||||||||||
Proteostasis in endoplasmic reticulum—new mechanisms in kidney disease Reiko Inagi, Yu Ishimoto & Masaomi Nangaku Published online: 22 April 2014 p369 | doi:10.1038/nrneph.2014.67 In the endoplasmic reticulum (ER), networks of protein homeostasis—proteostasis—regulate protein synthesis, folding and degradation via the unfolded protein response (UPR) pathway. A defective UPR is deleterious to renal cell function and viability and is implicated in the pathophysiology of various kidney pathologies. Here, the authors discuss the role of oxidative, glycative and hypoxic stress and how optimizing ER proteostasis might prevent and treat kidney diseases. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
Lipid biology of the podocyte—new perspectives offer new opportunities Alessia Fornoni, Sandra Merscher & Jeffrey B. Kopp Published online: 27 May 2014 p379 | doi:10.1038/nrneph.2014.87 Fornoni et al. discuss the role of lipid biology in podocytes in the pathogenesis of glomerulopathies focusing on diabetic kidney disease and focal segmental glomerulosclerosis. They outline recent findings from genetic disorders that highlight the function of apolipoproteins in the podocyte and discuss the therapeutic implications. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
B cells with immune-regulating function in transplantation Jessica Stolp, Laurence A. Turka & Kathryn J. Wood Published online: 20 May 2014 p389 | doi:10.1038/nrneph.2014.80 Data from studies in humans and rodents suggest that B cells have the capacity to control or regulate the immune response to a transplanted organ. Here, the authors describe the phenotypes and mechanisms that have been associated with regulatory B cell function and discuss the evidence for a role of these cells in transplant tolerance. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
Pattern recognition receptors and the inflammasome in kidney disease Jaklien C. Leemans, Lotte Kors, Hans-Joachim Anders & Sandrine Florquin Published online: 03 June 2014 p398 | doi:10.1038/nrneph.2014.91 In this Review, the authors discuss the pathological mechanisms related to Toll-like receptors, nucleotide-binding oligomerization domain receptors and the NACHT, LRR and PYD domains-containing protein 3 inflammasome in various kidney diseases. Although these receptors are protective in the host defence against urinary tract infection, they can perpetuate tissue damage in sterile inflammatory and immune-mediated kidney diseases—making them promising drug targets. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
PERSPECTIVES | Top | |||||||||||||||||||||||||||||||||||||
OPINION Hyperosmolarity drives hypertension and CKD—water and salt revisited Richard J. Johnson, Bernardo Rodriguez-Iturbe, Carlos Roncal-Jimenez, Miguel A. Lanaspa, Takuji Ishimoto, Takahiko Nakagawa, Ricardo Correa-Rotter, Catharina Wesseling, Lise Bankir & Laura G. Sanchez-Lozada Published online: 06 May 2014 p415 | doi:10.1038/nrneph.2014.76 Recurrent dehydration and salt loss might be a mechanism that causes chronic kidney disease, whereby increased plasma osmolarity activates both intrarenal (polyol-fructokinase) and extrarenal (vasopressin) pathways to drive injury. The authors propose that water and salt influence blood pressure through the timing and combination of their intake, affecting plasma osmolarity and intrarenal and extrarenal mechanisms of renal injury. Abstract | Full Text | PDF | ||||||||||||||||||||||||||||||||||||||
Advertisement | ||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
|
*Journal Citation Reports, Thomson, 2012. Nature Reviews Nephrology was previously published as Nature Clinical Practice Nephrology. |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
No comments:
Post a Comment
Keep a civil tongue.